Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Apolipoprotein E e4 allele is associated with more rapid motor decline in older persons.

Buchman AS, Boyle PA, Wilson RS, Beck TL, Kelly JF, Bennett DA.

Alzheimer Dis Assoc Disord. 2009 Jan-Mar;23(1):63-9.

2.

Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.

Lee JH, Cheng R, Graff-Radford N, Foroud T, Mayeux R; National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group..

Arch Neurol. 2008 Nov;65(11):1518-26. doi: 10.1001/archneur.65.11.1518.

3.

Estimation of the multiple testing burden for genomewide association studies of nearly all common variants.

Pe'er I, Yelensky R, Altshuler D, Daly MJ.

Genet Epidemiol. 2008 May;32(4):381-5. doi: 10.1002/gepi.20303.

PMID:
18348202
4.

Pathological correlates of dementia in a longitudinal, population-based sample of aging.

Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellenberg GD, Craft S, Leverenz JB, Montine TJ.

Ann Neurol. 2007 Oct;62(4):406-13.

PMID:
17879383
5.

Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.

Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.

Arch Neurol. 2007 Sep;64(9):1306-11.

PMID:
17846270
6.

Genetics of Alzheimer's disease: a centennial review.

Ertekin-Taner N.

Neurol Clin. 2007 Aug;25(3):611-67, v. Review.

7.

Exploring candidate gene associations with neuropsychological performance.

McQueen MB, Bertram L, Lange C, Becker KD, Albert MS, Tanzi RE, Blacker D.

Am J Med Genet B Neuropsychiatr Genet. 2007 Dec 5;144B(8):987-91.

PMID:
17579348
8.

Mixed brain pathologies account for most dementia cases in community-dwelling older persons.

Schneider JA, Arvanitakis Z, Bang W, Bennett DA.

Neurology. 2007 Dec 11;69(24):2197-204. Epub 2007 Jun 13.

PMID:
17568013
9.

GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.

Reiman EM, Webster JA, Myers AJ, Hardy J, Dunckley T, Zismann VL, Joshipura KD, Pearson JV, Hu-Lince D, Huentelman MJ, Craig DW, Coon KD, Liang WS, Herbert RH, Beach T, Rohrer KC, Zhao AS, Leung D, Bryden L, Marlowe L, Kaleem M, Mastroeni D, Grover A, Heward CB, Ravid R, Rogers J, Hutton ML, Melquist S, Petersen RC, Alexander GE, Caselli RJ, Kukull W, Papassotiropoulos A, Stephan DA.

Neuron. 2007 Jun 7;54(5):713-20.

10.

A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.

Coon KD, Myers AJ, Craig DW, Webster JA, Pearson JV, Lince DH, Zismann VL, Beach TG, Leung D, Bryden L, Halperin RF, Marlowe L, Kaleem M, Walker DG, Ravid R, Heward CB, Rogers J, Papassotiropoulos A, Reiman EM, Hardy J, Stephan DA.

J Clin Psychiatry. 2007 Apr;68(4):613-8.

PMID:
17474819
11.

Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants.

Grupe A, Abraham R, Li Y, Rowland C, Hollingworth P, Morgan A, Jehu L, Segurado R, Stone D, Schadt E, Karnoub M, Nowotny P, Tacey K, Catanese J, Sninsky J, Brayne C, Rubinsztein D, Gill M, Lawlor B, Lovestone S, Holmans P, O'Donovan M, Morris JC, Thal L, Goate A, Owen MJ, Williams J.

Hum Mol Genet. 2007 Apr 15;16(8):865-73. Epub 2007 Feb 22.

PMID:
17317784
12.

Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study.

Bennett DA, Schneider JA, Aggarwal NT, Arvanitakis Z, Shah RC, Kelly JF, Fox JH, Cochran EJ, Arends D, Treinkman AD, Wilson RS.

Neuroepidemiology. 2006;27(3):169-76. Epub 2006 Oct 10.

13.

Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition.

Peskind ER, Li G, Shofer J, Quinn JF, Kaye JA, Clark CM, Farlow MR, DeCarli C, Raskind MA, Schellenberg GD, Lee VM, Galasko DR.

Arch Neurol. 2006 Jul;63(7):936-9.

PMID:
16831961
14.

Neuropathology of older persons without cognitive impairment from two community-based studies.

Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS.

Neurology. 2006 Jun 27;66(12):1837-44.

PMID:
16801647
15.

Neuropathologic features of amnestic mild cognitive impairment.

Petersen RC, Parisi JE, Dickson DW, Johnson KA, Knopman DS, Boeve BF, Jicha GA, Ivnik RJ, Smith GE, Tangalos EG, Braak H, Kokmen E.

Arch Neurol. 2006 May;63(5):665-72.

PMID:
16682536
16.
17.

A specific amyloid-beta protein assembly in the brain impairs memory.

Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH.

Nature. 2006 Mar 16;440(7082):352-7.

PMID:
16541076
18.

APOE, vascular pathology, and the AD brain.

Yip AG, McKee AC, Green RC, Wells J, Young H, Cupples LA, Farrer LA.

Neurology. 2005 Jul 26;65(2):259-65.

PMID:
16043796
19.

Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment.

Fleisher A, Grundman M, Jack CR Jr, Petersen RC, Taylor C, Kim HT, Schiller DH, Bagwell V, Sencakova D, Weiner MF, DeCarli C, DeKosky ST, van Dyck CH, Thal LJ; Alzheimer's Disease Cooperative Study..

Arch Neurol. 2005 Jun;62(6):953-7.

PMID:
15956166
20.

Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism.

Reiman EM, Chen K, Alexander GE, Caselli RJ, Bandy D, Osborne D, Saunders AM, Hardy J.

Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8299-302. Epub 2005 Jun 2.

Supplemental Content

Support Center